Health Canada Approves BENLYSTA(TM)
The First New Treatment for Systemic Lupus Erythematosus in Almost 50 Years
By Guest Column —— Bio and Archives--July 12, 2011
Health and Medicine | Comments | Back To Full Article
MISSISSAUGA, ON, July 12, 2011 /CNW/ - For the first time in almost 50 years Canadians living with lupus have a new treatment option. Health Canada has approved BENLYSTATM (belimumab), a new drug specific for the treatment of systemic lupus erythematosus (SLE, or simply lupus). The announcement was made today by GlaxoSmithKline Inc. (GSK) and Human Genome Sciences (HGS) who are developing BENLYSTATM under a co-development and co-commercialization agreement entered into in 2006. BENLYSTATM is expected to become available to patients in Canada in September of this year.
Read Full Article...
Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy